Addressing diversity barriers in prostate cancer clinical trials for equitable healthcare outcomes

Peter Lang; Matt Vassar

doi:10.1038/s41585-025-01008-8

Addressing diversity barriers in prostate cancer clinical trials for equitable healthcare outcomes

Research output: Contribution to journal › Comment/debate

Abstract

Prostate cancer is the most common cancer in men, yet disparities persist in screening, diagnosis and treatment among populations with low socioeconomic status. Minority groups face barriers to clinical trial inclusion including limited awareness and financial challenges. Promoting diversity in clinical trials is crucial for inclusivity, improving treatment efficacy and achieving equitable health outcomes in prostate cancer care.

Original language	English
Pages (from-to)	493-494
Number of pages	2
Journal	Nature Reviews Urology
Volume	22
Issue number	8
DOIs	https://doi.org/10.1038/s41585-025-01008-8
State	Published - Aug 2025

Access to Document

10.1038/s41585-025-01008-8

Cite this

@article{1a062f5cf29144cd82d951e1b9dbd838,

title = "Addressing diversity barriers in prostate cancer clinical trials for equitable healthcare outcomes",

abstract = "Prostate cancer is the most common cancer in men, yet disparities persist in screening, diagnosis and treatment among populations with low socioeconomic status. Minority groups face barriers to clinical trial inclusion including limited awareness and financial challenges. Promoting diversity in clinical trials is crucial for inclusivity, improving treatment efficacy and achieving equitable health outcomes in prostate cancer care.",

author = "Peter Lang and Matt Vassar",

note = "Publisher Copyright: {\textcopyright} Springer Nature Limited 2025.",

year = "2025",

month = aug,

doi = "10.1038/s41585-025-01008-8",

language = "English",

volume = "22",

pages = "493--494",

journal = "Nature Reviews Urology",

issn = "1759-4812",

publisher = "Nature Research",

number = "8",

}

TY - JOUR

T1 - Addressing diversity barriers in prostate cancer clinical trials for equitable healthcare outcomes

AU - Lang, Peter

AU - Vassar, Matt

N1 - Publisher Copyright: © Springer Nature Limited 2025.

PY - 2025/8

Y1 - 2025/8

N2 - Prostate cancer is the most common cancer in men, yet disparities persist in screening, diagnosis and treatment among populations with low socioeconomic status. Minority groups face barriers to clinical trial inclusion including limited awareness and financial challenges. Promoting diversity in clinical trials is crucial for inclusivity, improving treatment efficacy and achieving equitable health outcomes in prostate cancer care.

AB - Prostate cancer is the most common cancer in men, yet disparities persist in screening, diagnosis and treatment among populations with low socioeconomic status. Minority groups face barriers to clinical trial inclusion including limited awareness and financial challenges. Promoting diversity in clinical trials is crucial for inclusivity, improving treatment efficacy and achieving equitable health outcomes in prostate cancer care.

UR - https://www.scopus.com/pages/publications/85219659887

U2 - 10.1038/s41585-025-01008-8

DO - 10.1038/s41585-025-01008-8

M3 - Comment/debate

AN - SCOPUS:85219659887

SN - 1759-4812

VL - 22

SP - 493

EP - 494

JO - Nature Reviews Urology

JF - Nature Reviews Urology

IS - 8

ER -

Addressing diversity barriers in prostate cancer clinical trials for equitable healthcare outcomes

Abstract

Access to Document

Other files and links

Fingerprint

Cite this